Sugi Predict

Sugi Predict / Compounds / Ethylene Glycol

Ethylene Glycol

Ethylene Glycol

SCHEMBL23356751

C=C.C=C.C=C.C=C.C=C.C=C.CCCCCCCCOC.OCCO

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ THRB P10828 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ TSHR P16473 4/20 0.48
▸ LMNA P02545 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ LPAR3 Q9UBY5 6/20 0.45
▸ LPAR2 Q9HBW0 5/20 0.45
▸ LPAR1 Q92633 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ USP2 O75604 1/20 0.41
▸ NAAA Q02083 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL23356953 1.00 MEN1 (0.52) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL23356966 1.00 MEN1 (0.52) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL17076605 1.00 MEN1 (0.52) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL23356792 1.00 MEN1 (0.52) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL23357155 1.00 MEN1 (0.52) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL23356872 1.00 MEN1 (0.52) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL23391392 0.95 MEN1 (0.56) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL23391390 0.95 MEN1 (0.56) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL17076606 0.95 MEN1 (0.56) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL3457373 0.95 MEN1 (0.56) MEN1KMT2ATHRBHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12597635-B2 Electrochemical device MURATA MANUFACTURING CO., LTD. (JP) 2026-04-07 — — US disclosed
CN-116918095-A Positive electrode and electrochemical device 株式会社村田制作所 2023-10-20 — — CN disclosed
US-20230223525-A1 ELECTROCHEMICAL DEVICE MURATA MANUFACTURING CO., LTD. (JP) 2023-07-13 — — US disclosed
CN-116250124-A Electrochemical device 株式会社村田制作所 2023-06-09 — — CN disclosed
WO-2022209595-A1 POSITIVE ELECTRODE AND ELECTROCHEMICAL DEVICE 株式会社村田製作所 2022-10-06 — — WO disclosed
WO-2022054813-A1 ELECTROCHEMICAL DEVICE 株式会社村田製作所 2022-03-17 — — WO disclosed
EP-3832772-A1 ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE Murata Manufacturing Co., Ltd. (JP) 2021-06-09 — — EP disclosed
US-20210151803-A1 ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE MURATA MANUFACTURING CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12597635-B2 Electrochemical device CLCN2, HCN4, SLC26A3 MEN1 1871/4885KMT2A 2323/4885THRB 2677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.